Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure.
June Hwa BaeJung-Bin ParkJi Eun BaekSeung Wook HongSang Hyoung ParkDong-Hoon YangByong Duk YeSeung Wook HongSeung-Jae MyungSuk-Kyun YangSung Wook HwangPublished in: Gut and liver (2024)
In UC patients who experience IV infliximab failure during maintenance treatment, switching to SC infliximab may be a promising option because of better efficacy and safety.